# OnCo record simplescreen-crc (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/simplescreen-crc/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "simplescreen-crc" ;
  schema:name "SimpleScreen CRC"@en ;
  schema:description "The second FDA-approved blood test for bowel cancer screening, from Freenome, sold by Abbott from late 2026."@en ;
  schema:url <https://onco.cc/drugs/simplescreen-crc/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2025.7515>, <https://www.medtechdive.com/news/freenome-secures-fda-nod-for-blood-based-colorectal-cancer-test/826290/>, <https://www.freenome.com> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Blood-based colorectal cancer screening test (cfDNA methylation and protein)" ;
  schema:alternateName "SimpleScreen" ;
  onco:approval "US 2026: Colorectal cancer screening in average-risk adults aged 45 and older" ;
  onco:related <https://onco.cc/drugs/shield/>, <https://onco.cc/drugs/cologuard-plus/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:companies <https://onco.cc/companies/freenome/>, <https://onco.cc/companies/abbott/> ;
  onco:terms <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/sensitivity-specificity/> ;
  onco:trials <https://onco.cc/trials/preempt-crc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-preempt-crc-shaukat-jama-2025/> .